Doc.ai, Inc. is a developer of artificial intelligence (AI) powered medical research platforms accessible through mobile and desktop. The company's AI technology is a decentralized, edge-learning network that performs deep learning computation on a smartphone, to develop insights based on users' health data.
Scope
- This report provides insights into doc.ai, including an overview of the company and its product offering, detailed coverage of its business model and operations, information on its funding and partnerships, and biographies of its senior management
Reasons to Buy
- Gain insights into Doc.ai, Inc. business operations
- Gain insights into its partnerships and funding
- Gain an understanding of its technology focus
Table of Contents
- Company Overview
- Technology Focus
- Product Overview
- Partnership
- Funding
- Key Employees
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ignyte Healthcare Strategies LLC.
- Anthem
- UCB Biopharma
- Kailos Genetics
- Stanford University School of Medicine
- uBiome
- Apple
- Storj Labs
- Deloitte Life Sciences and Healthcare
